Iterum Therapeutics (ITRMF) Q1 2026 Earnings

12MarConfirmed
Q1 1
Q1 2026
-0.2
-0.17
-0.13
-0.1

Details

Expected EPS
-0.145
Actual EPS
-0.2
Surprise EPS
-0.06
Surprise Percent
+37.93%

Description

Iterum Therapeutics (ITRMF) has reported earnings of -0.2 per share for Q1 2026.

0 Comments

Share your thoughts